We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GNLX market cap is 100.35M. The company's latest EPS is USD -0.8177 and P/E is -3.56.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 8k | 0 | 0 |
| Operating Income | -5.31M | -7M | -8.12M | -6.89M | -6.94M |
| Net Income | -5.35M | -6.77M | -7.85M | -6.58M | -6.47M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 11.07M | 170k |
| Operating Income | -14.61M | -3.01M | -24.17M |
| Net Income | -16.38M | -5.21M | -28.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 34.07M | 27.89M | 24.68M | 45.18M | 40.27M |
| Total Liabilities | 10.04M | 8.42M | 9.59M | 7.51M | 7.18M |
| Total Equity | 24.03M | 19.47M | 15.08M | 37.67M | 33.09M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.13M | 5.53M | 27.89M |
| Total Liabilities | 41.24M | 41.31M | 8.42M |
| Total Equity | -33.11M | -35.78M | 19.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -13.37M | -20.28M | -4.35M | -11.18M | -16.93M |
| Investing | -782k | -14.72M | -1.69M | -18.8M | -14.81M |
| Financing | 43.62M | 44.02M | 688k | 28.42M | 28.42M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.59M | -3.57M | -20.28M |
| Investing | N/A | -49k | -14.72M |
| Financing | -270k | -478k | 44.02M |
| Market Cap | 100.35M |
| Price to Earnings Ratio | -3.56 |
| Price to Sales Ratio | 593.88 |
| Price to Cash Ratio | 10.69 |
| Price to Book Ratio | 5.17 |
| Dividend Yield | - |
| Shares Outstanding | 34.6M |
| Average Volume (1 week) | 93.44k |
| Average Volume (1 Month) | 218.43k |
| 52 Week Change | -14.20% |
| 52 Week High | 5.885 |
| 52 Week Low | 1.60 |
| Spread (Intraday) | 0.35 (11.18%) |
| Company Name | Genelux Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.genelux.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
